EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050

Jian Xu, Jingyu Liu, Xiaowei Li, Liang Zhao, Jianzhong Shen, Xi Xia

Journal of Advanced Research · 2026

DOI: 10.1016/j.jare.2025.06.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Research, 2026. Verfasst von Jian Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Anti-Bacterial Agents, Bacterial Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Antimicrobial resistance (AMR) has emerged as a critical health challenge; however, there is a paucity of in-depth reports outlining its burden and trends in China. OBJECTIVES: This study aimed to systematically assess the burden of bacterial AMR in China from 1990 to 2021 and project future trends up to 2050, providing critical insights for AMR control and policy-making. METHODS: We analyzed data from the Global Burden of Disease Study 2021, encompassing 12 infectious syndromes, 64 pathogens (including 22 with AMR), and 84 pathogen-drug combinations. The burden was quantified by deaths and disability-adjusted life years under two counterfactual scenarios: those associated with AMR and those attributable to AMR. Trends were assessed using joinpoint regression analysis, and future projections up to 2050 were modeled using an autoregressive integrated moving average approach. RESULTS: In 2021, AMR was attributable to approximately 160,268 (95% uncertainty intervals [UI]: 132,375-188,160) deaths in China, with up to 711,852 (95% UI: 586,447-837,256) fatalities associated with AMR. The most lethal infectious syndrome was bloodstream infections, with key pathogen-drug combinations including methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Streptococcus pneumoniae, and carbapenem-resistant Acinetobacter baumannii. Between 1990 and 2021, there was a substantial decrease in the burden among children under the age of five, primarily due to a decline in fatalities caused by carbapenem-resistant S. pneumoniae. In contrast, the burden increased among individuals aged 45 and older, with MRSA identified as the principal contributor. Projections indicate that by 2050, AMR could be associated with 769,432 deaths in China, of which 180,123 directly attributable to AMR. CONCLUSION: Our findings provide a comprehensive evaluation of AMR burden in China, highlighting the urgent need for targeted interventions to prevent and control resistant infections, particularly among older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialAnti-Bacterial AgentsBacterial InfectionsHumansChinaMiddle AgedAdultAgedMaleChildDisability-Adjusted Life YearsChild, PreschoolBacteriaAdolescentFemaleYoung AdultGlobal Burden of Disease

Stichwörter der Autor:innen

Antimicrobial resistanceBurden of infectious diseasesDisability-adjusted life years

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China. Electronic address: sjz@cau.edu.cn.
  • National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China. Electronic address: xxia@cau.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Xu, J., Liu, J., Li, X., Zhao, L., Shen, J., & Xia, X. (2026). Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2025.06.021

Vancouver

Xu J, Liu J, Li X, Zhao L, Shen J, Xia X. Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050. Journal of Advanced Research. 2026. doi:10.1016/j.jare.2025.06.021

BibTeX
@article{Xu2026,
  author = {Xu, Jian and Liu, Jingyu and Li, Xiaowei and Zhao, Liang and Shen, Jianzhong and Xia, Xi},
  title = {Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050},
  journal = {Journal of Advanced Research},
  year = {2026},
  doi = {10.1016/j.jare.2025.06.021}
}
Kostenlos starten →